ST6Gal-I is upregulated across different cancer types, including breast, gliomas, pancreatic, prostate, and ovarian cancer, and plays a fundamental role in tumor progression, epithelial-to-mesenchymal transition, and metastasis (24, 25, 26, 27, 28). Here, ST6GAL1 is linked to cancer.